Hypertension and dyslipidemia combined therapeutic approaches

C Borghi, F Fogacci, D Agnoletti, AFG Cicero - High Blood Pressure & …, 2022 - Springer
Treating blood pressure (BP) alone may provide only limited benefits while it is
recommendable to manage the total cardiovascular risk. To date, several studies have …

Angiotensin II, hypercholesterolemia, and vascular smooth muscle cells: a perfect trio for vascular pathology

A St. Paul, CB Corbett, R Okune, MV Autieri - International Journal of …, 2020 - mdpi.com
Cardiovascular disease is the leading cause of morbidity and mortality in the Western and
developing world, and the incidence of cardiovascular disease is increasing with the longer …

Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes

I Lingvay, N Beetz, R Sennewald… - Postgraduate …, 2020 - Taylor & Francis
Objectives Fixed-dose combination (FDC) therapy can improve outcomes in type 2 diabetes
(T2D). We evaluated the bioequivalence of 2 doses of an FDC of extended-release …

Effect of Hibiscus sabdariffa and Zingiber officinale on pharmacokinetics and pharmacodynamics of amlodipine

MA Alam, YA Bin Jardan, B Alzenaidy… - Journal of Pharmacy …, 2021 - academic.oup.com
Objectives To study the effect of Zingiber officinale and Hibiscus sabdariffa on
pharmacokinetics and pharmacodynamics of amlodipine. Methods Hypertension was …

[PDF][PDF] 丹参酮ⅡA 联合阿托伐他汀对大鼠动脉粥样硬化的治疗作用研究

叶泽森, 周里岩, 黄光业, 薛照芸, 刘培庆… - 生命科学 …, 2022 - smkx.hunnu.edu.cn
阿托伐他汀和丹参酮ⅡA 在临床上已用于治疗动脉粥样硬化. 然而, 两者联用治疗动脉粥样硬化
的协同作用仍不明确. 为了考察丹参酮ⅡA 联合阿托伐他汀能否增强阿托伐他汀对动脉粥样硬化 …

Effect of Nigella sativa and Fenugreek on the Pharmacokinetics and Pharmacodynamics of Amlodipine in Hypertensive Rats

MA Alam, YA Bin Jardan, M Raish… - Current Drug …, 2020 - ingentaconnect.com
Background: The present article is related to in-vitro and in-vivo herb-drug interaction
studies. Objectives: This study aimed to investigate the effect of Nigella sativa and fenugreek …

Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart …

AFG Cicero, F Fogacci, E Rizzoli, M Giovannini… - Nutrition, Metabolism …, 2022 - Elsevier
Background and aims To evaluate the long-term effect of simultaneous treatment of
hypertension and hypercholesterolemia with angiotensin-converting enzyme (ACE) …

Herb–drug interaction: pharmacokinetics and pharmacodynamics of anti-hypertensive drug amlodipine besylate in presence of Lepidium sativum and Curcuma longa

MA Alam, YA Bin Jardan, M Raish, AM Al-Mohizea… - Xenobiotica, 2022 - Taylor & Francis
Abstract Effects of Lepidium sativum and Curcuma longa were investigated on
pharmacokinetics and pharmacodynamics of antihypertensive drug (amlodipine) …

[HTML][HTML] Медикаментозная терапия артериальной гипертонии и дислипидемии: возможности препарата Липертанс (на примере клинического наблюдения)

ВВ Кашталап - Российский кардиологический журнал, 2022 - cyberleninka.ru
В статье, проиллюстрированной клиническим наблюдением, представлены
эпидемиологические данные о высокой распространенности коморбидности …

[HTML][HTML] Возможности применения комбинированной терапии у пациентов c сочетанием артериальной гипертензии и дислипидемии

ТВ Горохова, НБ Перепеч - Российский кардиологический …, 2022 - cyberleninka.ru
В настоящей статье представлен обзор имеющихся данных о роли артериальной
гипертензии и дислипидемии как ведущих факторов, определяющих характер …